Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Altcoins fell along with the broader market, with OP, NEAR and others dropping by 10% in 24 hours

Altcoins fell along with the broader market, with OP, NEAR and others dropping by 10% in 24 hours

2024/01/23 09:30
According to market data, altcoins are following the general market trend and experiencing a widespread drop. Previously strong high-market-cap cryptocurrencies such as OP, NEAR have seen a 24-hour decline of up to 10%. Specifically: NEAR is now priced at $2.54, with a 24-hour decrease of 10.28%; OP is now priced at $2.75, with a 24-hour decrease of 10.48%; AVAX is now priced at $28.27, with a 24-hour decrease of 10.1%; SOL is now priced at $80.8, with a 24-hour decrease of 8.66%; JTO is now priced at $1.91, with a 24-hour decrease of 8.79%; STX is now priced at $1.29, with a 24-hour decrease of 8.48%.
1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma

GlaxoSmithKline announced on Tuesday that it has reached an agreement with Chinese biotechnology company ImmuneOnco to acquire the global rights to one of the latter’s trispecific T-cell engagers (TCE) for a total transaction amount of up to $750 million.

智通财经2026/09/15 08:06
GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma